title: [Adequate empiric therapy of nosocomial fungal infections in oncologic patients of intensive care units].
abstract: The results of a 3-year experience with voriconasole in oncologic practice are presented. Rational schemes for the use of caspofungin and mycofungin in the treatment of oncologic inpatients and the criteria of their use in the therapy of fungal nosocomial infections were developmed. Good clinical and microbiological efficacy of caspofungin and mycofungin against Candida non-albicans was shown.
authors.forename: S D
authors.initials: SD
authors.lastname: Mitrokhin
authors.forename: I N
authors.initials: IN
authors.lastname: Fedankov
authors.forename: A Zh
authors.initials: AZh
authors.lastname: Khoteev
authors.forename: A A
authors.initials: AA
authors.lastname: Sokolov
mesh_terms: D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D000077336:Caspofungin; D003428:Cross Infection / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D025141:Drug Resistance, Fungal / Q000187:drug effects; D054714:Echinocandins / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D055666:Lipopeptides / Q000627:therapeutic use; D008297:Male; D000077551:Micafungin; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077336:Caspofungin; D000077551:Micafungin